QIAGEN N.V. QGEN recently signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic ...

diluted EPS outlook reaffirmed for about $2.35 CER QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today confirmed strong Q1 2025 results in line with the preliminary announcement and ...

PL VENLO, Netherlands (AP) — PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Wednesday reported first-quarter profit of $90.8 million. On a per-share basis, the Pl Venlo, Netherlands-based ...

Qiagen is a Netherlands-incorporated life sciences tools firm, dual-listed in the U.S. and Germany. The company provides sample technologies to isolate and process DNA, RNA and proteins ...

VENLO, the Netherlands–(BUSINESS WIRE)–QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) ...

To learn more about QIAGEN’s latest innovations, visit booth #2620 at the AACR Annual Meeting 2025. More details about featured talks, poster presentations and product demonstrations are ...

Activist investor Fivespan Partners has accumulated a position in Dutch diagnostics firm Qiagen NV (NYSE:QGEN). The activist investor has had constructive talks with Qiagen's management team ...

Three new innovative instrument launches expand reach into further lab segments and sample preparation customers as QIAGEN strengthens market-leading position QIAsymphony Connect set to start phased ...